© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
July 22, 2021
Red flags that would prompt a pharmacist to refer a patient with migraine to be evaluated by a physician.
What community pharmacists need to know about migraine treatment and their role in educating and managing patients.
July 15, 2021
An overview of CGRP antagonists approved as preventive therapy for migraine and recommendations for appropriate dosing and administration to patients.
Factors that need to be considered when determining patient candidacy for over-the-counter herbal products and nutritional supplements available as preventive therapy for migraine and recommendations for educating patients about their use.
July 12, 2021
Researchers hypothesized that people may look for the UV-B type of UV light because they are unaware of their need for endorphins.
July 08, 2021
Preventive therapies available for patients who require migraine prophylaxis and factors that impact treatment selection.
Jennifer L. Mazan, PharmD, describes the role of CGRP antagonists as acute migraine treatment and shares considerations for selecting and using these therapies.
July 06, 2021
As the first point of contact at many pharmacies, technicians can often see whether a patient has been prescribed an opioid or other monitored substances.
July 01, 2021
Special considerations for counseling patients and prescribing lasmiditan, a targeted 5-HT1F therapy approved as acute migraine treatment.
Timothy Smith, MD, RPh, FACP, AQH, describes goals of therapy for the acute treatment of migraine and reacts to current treatment limitations associated with available drug therapies.